Gastus - Company finances
|
EUR
|
2020
From: 2020-12-02
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | - | 46,300 | 51,000 | 194,400 | 220,256 | 79,499 |
| Profit before tax | -176 | -17,677 | -9,561 | -228,117 | -231,543 | -267,147 |
| Net profit | -176 | -17,677 | -9,561 | -228,117 | -231,543 | -267,147 |
| Equity | 2,324 | -15,353 | -24,914 | -261,872 | -5,226,468 | -5,507,315 |
| Liabilities | 173 | 201,021 | 421,646 | 2,757,225 | 7,894,912 | 7,243,073 |
| Non-current assets | 0 | 31,667 | 325,665 | 2,127,738 | 2,114,498 | 2,905 |
| Current assets | 2,497 | 152,861 | 71,067 | 367,615 | 553,946 | 1,732,853 |
| Total assets | 2,497 | 184,528 | 396,732 | 2,495,353 | 2,668,444 | 1,735,758 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 1,378 | 1,842 | 958 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | +10.2% | +281.2% | +13.3% | -63.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -7.0% | -9.6% | -2.4% | -9.1% | -8.7% | -15.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -7.6% | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -38.2% | -18.7% | -117.3% | -105.1% | -336.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -38.2% | -18.7% | -117.3% | -105.1% | -336.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 46,300 | 51,000 | 194,400 | 220,256 | 79,499 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gastus - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-05-02 | 2023-07-09 | 1.75 |
| 2023-04-26 | 2023-04-28 | 1.75 |
| 2023-04-18 | 2023-04-25 | 1.73 |
| 2023-03-16 | 2023-04-12 | 1.73 |
| 2023-02-17 | 2023-03-13 | 1.92 |
| 2022-12-16 | 2022-12-19 | 81.89 |
| 2022-09-16 | 2022-10-09 | 0.30 |
| 2022-08-23 | 2022-09-11 | 0.30 |
| 2022-07-25 | 2022-08-09 | 0.30 |
| 2022-07-18 | 2022-07-24 | 0.28 |
| 2022-05-17 | 2022-07-12 | 0.28 |
| 2022-04-19 | 2022-05-11 | 0.28 |
| 2022-03-16 | 2022-04-14 | 0.28 |
| 2022-02-17 | 2022-03-06 | 0.28 |
| 2022-01-31 | 2022-02-09 | 0.28 |
| 2022-01-18 | 2022-01-30 | 0.18 |
| 2021-12-16 | 2022-01-13 | 0.18 |
| 2021-11-16 | 2021-12-13 | 0.18 |
| 2021-10-19 | 2021-11-14 | 0.18 |
| 2021-10-18 | 2021-10-18 | 81.24 |
| 2021-09-16 | 2021-10-17 | 0.18 |
Gastus - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gastus, UAB (code 305664912) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In 2025, revenue declined to €79.5K, down from €220.3K in 2024 and €194.4K in 2023, showing a marked contraction in sales over two years. Net loss widened to €267.1K in 2025, compared with losses of €231.5K in 2024 and €228.1K in 2023, so the company remained loss-making throughout the period. Balance-sheet indicators also weakened: total assets fell to €1.74M in 2025 from €2.67M a year earlier and €2.50M in 2023. Equity stayed deeply negative at -€5.51M, while liabilities stood at €7.24M. Long-term assets were reduced to €2.9K, and short-term assets amounted to €1.73M. Asset turnover was 0.05x, indicating limited revenue generation relative to the asset base, and revenue per employee was €79.5K. The 2025 figures point to continued financial strain and weak operating performance.